STERIS plc (STE) Financials

STE Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 10.7 billion 3.5 billion
Dec. 31, 2025 10.6 billion 3.4 billion
Sept. 30, 2025 10.4 billion 3.4 billion
June 30, 2025 10.4 billion 3.4 billion

STE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 245.2 million 45.0 million
Dec. 31, 2025 199.5 million 15.7 million
Sept. 30, 2025 201.3 million 21.2 million
June 30, 2025 326.4 million 11.9 million

STE Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 220.3 million
Dec. 31, 2025 194.4 million
Sept. 30, 2025 192.4 million
June 30, 2025 178.0 million

STE Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 439.6 million 1.8 billion -
Dec. 31, 2025 423.7 million 1.9 billion 155.3 million
Sept. 30, 2025 319.2 million 1.9 billion 161.3 million
June 30, 2025 279.7 million 1.9 billion 165.7 million

STE Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 ?
Dec. 31, 2025 98.8 million
Sept. 30, 2025 98.8 million
June 30, 2025 98.8 million

STE Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 90.2 million 28.8 million 351.8 million -
Dec. 31, 2025 98.7 million 29.5 million 352.4 million -
Sept. 30, 2025 86.5 million 28.2 million 349.7 million -
June 30, 2025 93.6 million 26.4 million 353.8 million -

STE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 1.6 billion 891.3 million
Dec. 31, 2025 1.5 billion 840.6 million
Sept. 30, 2025 1.5 billion 814.4 million
June 30, 2025 1.4 billion 763.1 million

STE Revenue by Segment
Graph available only for paid members. Upgrade to see it.

STE

List: Contenders

Price: $209.34

52 week price:
195.14
269.44

Dividend Yield: 1.17%

5-year range yield:
0.76%
1.21%

Forward Dividend Yield: 1.21%

Payout Ratio: 40.28%

Payout Ratio Range:
-3732.53%
800.00%

Dividend Per Share: 2.52 USD

Earnings Per Share: 7.93 USD

P/E Ratio: 26.75

Exchange: NYQ

Sector: Healthcare

Industry: Medical Devices

Country: Ireland

Volume: 489871

Ebitda: 149.1 million

Market Capitalization: 20.5 billion

Average Dividend Frequency: 4

Years Paying Dividends: 22

DGR3: 9.85%

DGR5: 9.03%

DGR10: 9.51%

DGR20: 30.00%

Links: